Compare TXT & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXT | EXEL |
|---|---|---|
| Founded | 1923 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 14.0B |
| IPO Year | 1994 | 2000 |
| Metric | TXT | EXEL |
|---|---|---|
| Price | $87.89 | $52.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 21 |
| Target Price | ★ $95.18 | $46.50 |
| AVG Volume (30 Days) | 1.7M | ★ 2.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.09% | N/A |
| EPS Growth | 18.01 | ★ 57.95 |
| EPS | ★ 2.67 | 1.60 |
| Revenue | ★ $14,799,000,000.00 | $452,477,000.00 |
| Revenue This Year | $5.87 | $13.61 |
| Revenue Next Year | $4.54 | $13.13 |
| P/E Ratio | ★ $33.13 | $71.77 |
| Revenue Growth | ★ 8.01 | N/A |
| 52 Week Low | $76.93 | $33.76 |
| 52 Week High | $101.57 | $57.57 |
| Indicator | TXT | EXEL |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 41.45 |
| Support Level | $86.84 | $50.80 |
| Resistance Level | $93.29 | $52.84 |
| Average True Range (ATR) | 2.66 | 1.64 |
| MACD | -0.28 | -0.34 |
| Stochastic Oscillator | 33.01 | 10.61 |
Textron is a conglomerate that designs, manufactures, and services a range of specialty aircraft including small jets, propeller-driven airplanes, helicopters, and tilt-rotor aircraft. Textron Aviation manufactures and services Cessna and Beechcraft planes. Bell is a helicopter and tilt-rotor manufacturer and servicer for both commercial and military customers. Textron Systems produces uncrewed aircraft and armored vehicles for the military market as well as aircraft simulators and training for the commercial and military markets. Textron Industrial houses the Kautex business, which manufactures plastic fuel tanks for conventional and hybrid motor vehicles, and other subsidiaries that produce specialized vehicles such as golf carts and all-terrain vehicles.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.